Púrpura trombótica trombocitopénica
- 1 April 2011
- journal article
- review article
- Published by Elsevier in Medicina Clinica
- Vol. 136 (12) , 534-540
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpuraKidney International, 2009
- Thrombotic Thrombocytopenic Purpura: A Thrombotic Disorder Caused by ADAMTS13 DeficiencyHematology/Oncology Clinics of North America, 2007
- Atypical haemolytic uraemic syndromeBritish Medical Bulletin, 2006
- Novel monoclonal antibody‐based enzyme immunoassay for determining plasma levels of ADAMTS13 activityTransfusion, 2006
- Thrombotic Thrombocytopenic Purpura: aetiology, pathophysiology and treatmentBlood Reviews, 2006
- Von Willebrand factor–cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpuraBlood, 2002
- Laboratory abnormalities in thrombotic thrombocytopenic purpuraBritish Journal of Haematology, 1998
- Successful use of cyclosporine A in the treatment of refractory thrombotic thrombocytopenic purpuraBritish Journal of Haematology, 1998
- Treatment of Thrombotic Thrombocytopenic Purpura with PlasmaNew England Journal of Medicine, 1977
- Thrombotic thrombocytopenic purpura as a cause of pancreatitisDigestive Diseases and Sciences, 1973